@article{d68f82b1748f4464ad61ba4b6da26525,
title = "Lipoproteins for therapeutic delivery: Recent advances and future opportunities",
abstract = "The physiological role(s) of mammalian plasma lipoproteins is to transport hydrophobic molecules (primarily cholesterol and triacylglycerols) to their respective destinations. Lipoproteins have also been studied as drug-delivery agents due to their advantageous payload capacity, long residence time in the circulation and biocompatibility. The purpose of this review is to briefly discuss current findings with the focus on each type of formulation's potential for clinical applications. Regarding utilizing lipoprotein type formulation for cancer therapeutics, their potential for tumor-selective delivery is also discussed.",
keywords = "HDL, LDL, cancer therapy, discoidal nanoparticles, drug delivery, lipoproteins, rHDL",
author = "Sangram Raut and Dasseux, {Jean Louis} and Sabnis, {Nirupama A.} and Linda Mooberry and Andras Lacko",
note = "Funding Information: The authors{\textquoteright} research was supported by Cancer Prevention and Research Institute of Texas (DP150091), The Peggy Dickerman Brain Cancer Research Fund and the Rutledge Foundation, Fort Worth, TX, USA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Publisher Copyright: {\textcopyright} 2018 Newlands Press.",
year = "2018",
doi = "10.4155/tde-2017-0122",
language = "English",
volume = "9",
pages = "257--268",
journal = "Therapeutic Delivery",
issn = "2041-5990",
publisher = "Future Science",
number = "4",
}